Novel Erythroid Cell Membrane Protein
新型红细胞膜蛋白
基本信息
- 批准号:7595979
- 负责人:
- 金额:$ 22.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAnemiaAntibodiesBiochemicalBioinformaticsBiologicalBiological ProcessBone MarrowCell Membrane ProteinsCell membraneCell physiologyCellsCellular biologyDevelopmentEmbryoEmbryonic DevelopmentEpitopesErythroblastsErythrocytesErythroidErythroid CellsErythroid Progenitor CellsErythropoiesisErythropoietinExhibitsFetal LiverGene TargetingGenesGeneticGenetic TranscriptionHematopoiesisHematopoietic stem cellsHemoglobin concentration resultImmunoglobulinsIn SituIn Situ HybridizationIntegral Membrane ProteinIslandKidney DiseasesKnockout MiceLymphopoiesisMalignant NeoplasmsMegakaryocytesMembrane ProteinsMessenger RNAMinorModelingMolecularMusPatientsPatternProtein FamilyProteinsReagentRoleSafetySignal TransductionSiteTestingTherapeutic AgentsZebrafishbaseeosinophilerythroid differentiationextracellularhuman GATA1 proteinintercellular cell adhesion moleculeintercellular communicationinterestknock-downloss of functionmacrophagemast cellmembernovelnovel strategiesparalogous geneprospectiveprotein structure functionpublic health relevancereceptortranscription factor
项目摘要
DESCRIPTION (provided by applicant): While erythropoietin (Epo) is commonly used to treat anemia in patients with cancer and kidney disease, recent studies have raised major safety concerns. There is great interest in developing new strategies to modulate erythropoiesis, and in this regard, we have been analyzing GATA transcription factor function. GATA-2 regulates the proliferation/survival of hematopoietic stem cells (HSCs), whereas GATA-1 promotes the differentiation of erythroid, megakaryocyte, eosinophil, and mast cells. Analysis of GATA-1 function in GATA-1-null erythroid precursor cells revealed a novel target gene, mFam55B. GATA-1 directly activates mFam55B transcription, and mFam55B expression is highly restricted to definitive erythroblasts in murine fetal liver and adult bone marrow. Although mFam55B has minor sequence similarity to Intercellular Cell Adhesion Molecule-4 (ICAM4), which is implicated in formation of functionally important erythroblastic islands, the bulk of mFam55B sequence does not resemble ICAM4 or other known proteins. mFam55B appears to be a Type II membrane protein, whereas ICAMs are Type I membrane proteins. We discovered four mammalian mFam55B-related genes, which have not been described, but only mFam55B is GATA-1-regulated. mFam55B is predicted to have a transmembrane helix and two extracellular immunoglobulin (Ig)-like repeats. mFam55B and its paralogs define a new protein family, and we hypothesize that mFam55B is an erythroid precursor membrane protein with important functions in erythroid cell biology. The following aims describe pilot/exploratory studies to develop reagents/models to define mFam55B function and to investigate the role of mFam55B in the formation of erythroblastic islands. Aim 1 - To determine whether mFam55B is a GATA-1-regulated transmembrane protein in erythroid precursor cells. We hypothesize that mFam55B is a transmembrane protein in erythroid precursor cells that functions via intercellular signaling. We will test whether GATA-1 regulates endogenous mFam55B levels, whether mFam55B exhibits predominant plasma membrane localization, and whether it resides in erythroblastic islands. Aim 2 - To investigate biological functions of mFam55B via loss-of-function studies in zebrafish and mice. We identified five novel zebrafish genes with significant sequence similarity to mFam55B. Knocking down one of these genes yielded severe anemia. We will knockdown the mFam55B-related genes to determine if they regulate erythropoiesis, will define their expression patterns, and will test whether their expression is GATA-1-dependent. We will also generate a mFam55B-null mouse to begin to dissect the role of mFam55B in erythroid cell function and/or erythropoiesis. PUBLIC HEALTH RELEVANCE: This project focuses on analyzing a novel GATA-1 regulated protein, mFam55B, that we discovered, which is predicted to be a single-pass transmembrane protein on erythroid precursor cells and to represent the founding member of a new protein family. As GATA-1 is a fundamental regulator of erythropoiesis, we hypothesize that mFam55B has important functions to regulate red blood cell development and/or erythroid precursor cell function. The proposed pilot/exploratory studies therefore have potential to yield high impact findings of relevance to novel strategies to stimulate red blood cell development, to elucidating how erythroid precursor cell function is altered in pathophysiological states, and to unraveling fundamental aspects of protein structure/function.
DESCRIPTION (provided by applicant): While erythropoietin (Epo) is commonly used to treat anemia in patients with cancer and kidney disease, recent studies have raised major safety concerns. There is great interest in developing new strategies to modulate erythropoiesis, and in this regard, we have been analyzing GATA transcription factor function. GATA-2 regulates the proliferation/survival of hematopoietic stem cells (HSCs), whereas GATA-1 promotes the differentiation of erythroid, megakaryocyte, eosinophil, and mast cells. Analysis of GATA-1 function in GATA-1-null erythroid precursor cells revealed a novel target gene, mFam55B. GATA-1 directly activates mFam55B transcription, and mFam55B expression is highly restricted to definitive erythroblasts in murine fetal liver and adult bone marrow. Although mFam55B has minor sequence similarity to Intercellular Cell Adhesion Molecule-4 (ICAM4), which is implicated in formation of functionally important erythroblastic islands, the bulk of mFam55B sequence does not resemble ICAM4 or other known proteins. mFam55B appears to be a Type II membrane protein, whereas ICAMs are Type I membrane proteins. We discovered four mammalian mFam55B-related genes, which have not been described, but only mFam55B is GATA-1-regulated. mFam55B is predicted to have a transmembrane helix and two extracellular immunoglobulin (Ig)-like repeats. mFam55B and its paralogs define a new protein family, and we hypothesize that mFam55B is an erythroid precursor membrane protein with important functions in erythroid cell biology. The following aims describe pilot/exploratory studies to develop reagents/models to define mFam55B function and to investigate the role of mFam55B in the formation of erythroblastic islands. Aim 1 - To determine whether mFam55B is a GATA-1-regulated transmembrane protein in erythroid precursor cells. We hypothesize that mFam55B is a transmembrane protein in erythroid precursor cells that functions via intercellular signaling. We will test whether GATA-1 regulates endogenous mFam55B levels, whether mFam55B exhibits predominant plasma membrane localization, and whether it resides in erythroblastic islands. Aim 2 - To investigate biological functions of mFam55B via loss-of-function studies in zebrafish and mice. We identified five novel zebrafish genes with significant sequence similarity to mFam55B. Knocking down one of these genes yielded severe anemia. We will knockdown the mFam55B-related genes to determine if they regulate erythropoiesis, will define their expression patterns, and will test whether their expression is GATA-1-dependent. We will also generate a mFam55B-null mouse to begin to dissect the role of mFam55B in erythroid cell function and/or erythropoiesis. PUBLIC HEALTH RELEVANCE: This project focuses on analyzing a novel GATA-1 regulated protein, mFam55B, that we discovered, which is predicted to be a single-pass transmembrane protein on erythroid precursor cells and to represent the founding member of a new protein family. As GATA-1 is a fundamental regulator of erythropoiesis, we hypothesize that mFam55B has important functions to regulate red blood cell development and/or erythroid precursor cell function. The proposed pilot/exploratory studies therefore have potential to yield high impact findings of relevance to novel strategies to stimulate red blood cell development, to elucidating how erythroid precursor cell function is altered in pathophysiological states, and to unraveling fundamental aspects of protein structure/function.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emery H Bresnick其他文献
Emery H Bresnick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emery H Bresnick', 18)}}的其他基金
New Tools to Decipher the Role of lncRNAs and Their Protein Interactomes in Hematopoiesis
破译lncRNA及其蛋白质相互作用组在造血作用中作用的新工具
- 批准号:
10368117 - 财政年份:2020
- 资助金额:
$ 22.28万 - 项目类别:
New Tools to Decipher the Role of lncRNAs and Their Protein Interactomes in Hematopoiesis
破译lncRNA及其蛋白质相互作用组在造血作用中作用的新工具
- 批准号:
10570964 - 财政年份:2020
- 资助金额:
$ 22.28万 - 项目类别:
Statistical Methods For Annotating Repetitive Genomic Regions Through ENCODE-deri
通过 ENCODE-deri 注释重复基因组区域的统计方法
- 批准号:
9060461 - 财政年份:2012
- 资助金额:
$ 22.28万 - 项目类别:
Novel Determinants of Terminal Erythroid Maturation
红细胞终末成熟的新决定因素
- 批准号:
8550827 - 财政年份:2012
- 资助金额:
$ 22.28万 - 项目类别:
Novel Determinants of Terminal Erythroid Maturation
红细胞终末成熟的新决定因素
- 批准号:
8681511 - 财政年份:2012
- 资助金额:
$ 22.28万 - 项目类别:
Novel Determinants of Terminal Erythroid Maturation
红细胞终末成熟的新决定因素
- 批准号:
8875745 - 财政年份:2012
- 资助金额:
$ 22.28万 - 项目类别:
Novel Determinants of Terminal Erythroid Maturation
红细胞终末成熟的新决定因素
- 批准号:
8417051 - 财政年份:2012
- 资助金额:
$ 22.28万 - 项目类别:
Statistical Methods For Annotating Repetitive Genomic Regions Through ENCODE-deri
通过 ENCODE-deri 注释重复基因组区域的统计方法
- 批准号:
8402305 - 财政年份:2012
- 资助金额:
$ 22.28万 - 项目类别:
相似国自然基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
- 批准号:82302715
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
- 批准号:31200592
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 22.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 22.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
- 批准号:
23K14452 - 财政年份:2023
- 资助金额:
$ 22.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
- 批准号:
23KJ0074 - 财政年份:2023
- 资助金额:
$ 22.28万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
- 批准号:
10752968 - 财政年份:2023
- 资助金额:
$ 22.28万 - 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
- 批准号:
10735765 - 财政年份:2023
- 资助金额:
$ 22.28万 - 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
- 批准号:
10735366 - 财政年份:2023
- 资助金额:
$ 22.28万 - 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
- 批准号:
10575222 - 财政年份:2023
- 资助金额:
$ 22.28万 - 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
- 批准号:
10583807 - 财政年份:2023
- 资助金额:
$ 22.28万 - 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:
10564553 - 财政年份:2023
- 资助金额:
$ 22.28万 - 项目类别:














{{item.name}}会员




